Stock 04K KNIGHT THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Knight Therapeutics Inc. Deutsche Boerse AG

Equities

04K

CA4990531069

Market Closed - Deutsche Boerse AG
Other stock markets
 07:02:46 28/06/2024 BST 		5-day change 1st Jan Change
3.76 EUR +0.53% Intraday chart for Knight Therapeutics Inc. +2.17% +6.82%
05-09 Knight Therapeutics Up Near 3% After Announcing Supply and Distribution Agreement For ADHD Medication; Despite Mixed Q1 MT
05-09 Transcript : Knight Therapeutics Inc., Q1 2024 Earnings Call, May 09, 2024

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Knight Therapeutics Price Target Raised to $7 at RBC
MT
National Bank Downgrades Knight Therapeutics to Sector Perform, Cuts Price Target to $6, on "Soft" Outlook
MT
Knight Therapeutics Hold Rating Maintained by Stifel GMP as Q2 Results Beat Forecasts; Price Target Raised to C$5.40
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GUD Stock
  4. 04K Stock
  5. News Knight Therapeutics Inc.
  6. Analyst Reco.